What was reported
Precision Neuroscience filed a Form D with the SEC on Sep 28, 2026 and reported $249,999,984 sold in an offering with no fixed total, with the first sale on Sep 11, 2026. 46 investors had invested.
What the evidence supports
Precision Neuroscience told the SEC, in a notice filed Sep 28, 2026, that it had $249,999,984 of securities sold in an offering exempt from registration under Rule 506(b).
What remains unknown
A Form D is a notice: the SEC does not review or approve it. It does not state the company's valuation, the price paid, who invested, or how the money will be used, and the amount can span several closings. Rule 506(b) bars general advertising and limits buyers mainly to accredited investors. This record describes a past sale; it is not an offer, and it does not mean shares are available to buy.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $249,999,984 | “Total amount sold: $249,999,984” Mentions: offering |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Amount sold to date (Form D; cumulative, not a valuation)Total amount sold: $249,999,984U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Sep 28, 2026 · Open the source ↗
Form D noticeForm D: notice of exempt offering of securities, filed with the SEC on 2026-09-28 (accession 0001123292-26-001327)U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Sep 28, 2026 · Open the source ↗
Industry group as stated by the companyIndustry group (as stated by the issuer): Other Health CareU.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Sep 28, 2026 · Open the source ↗
Date of first sale (Form D)Date of first sale: 2026-09-11U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Sep 28, 2026 · Open the source ↗
Investor count (Form D)Investors who have already invested: 46U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Sep 28, 2026 · Open the source ↗
Exemption claimed (Form D)Exemption claimed: Rule 506(b)U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Sep 28, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:54 UTC
Precision Neuroscience reports $250 million of securities sold in a private offering
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.